Small CRISPR RNAs guide antiviral defense in prokaryotes

Science. 2008 Aug 15;321(5891):960-4. doi: 10.1126/science.1159689.

Abstract

Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic acid into clusters of regularly interspaced short palindromic repeats (CRISPRs). Here we show how virus-derived sequences contained in CRISPRs are used by CRISPR-associated (Cas) proteins from the host to mediate an antiviral response that counteracts infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products containing the virus-derived sequence. Assisted by the helicase Cas3, these mature CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with virus proliferation. Our results demonstrate that the formation of mature guide RNAs by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement for antiviral defense.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Bacteriophage lambda* / genetics
  • Bacteriophage lambda* / growth & development
  • Base Sequence
  • DNA, Intergenic
  • DNA, Viral / metabolism
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Escherichia coli K12* / genetics
  • Escherichia coli K12* / metabolism
  • Escherichia coli K12* / virology
  • Escherichia coli Proteins* / chemistry
  • Escherichia coli Proteins* / genetics
  • Escherichia coli Proteins* / metabolism
  • Genes, Bacterial
  • Molecular Sequence Data
  • RNA Precursors / metabolism
  • RNA, Bacterial* / genetics
  • RNA, Bacterial* / metabolism
  • RNA, Small Untranslated
  • Repetitive Sequences, Nucleic Acid*
  • Transcription, Genetic
  • Viral Plaque Assay

Substances

  • DNA, Intergenic
  • DNA, Viral
  • Escherichia coli Proteins
  • RNA Precursors
  • RNA, Bacterial
  • RNA, Small Untranslated